{"id":23501,"date":"2025-05-22T09:39:42","date_gmt":"2025-05-22T09:39:42","guid":{"rendered":"https:\/\/makingpharmaindustry.it\/?p=23501"},"modified":"2025-05-22T09:39:42","modified_gmt":"2025-05-22T09:39:42","slug":"64-afi-symposium-maruti-e-porrello-about-the-third-session","status":"publish","type":"post","link":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/","title":{"rendered":"64\u00b0 AFI Symposium | Maruti e Porrello about the third session"},"content":{"rendered":"<p data-start=\"54\" data-end=\"424\">The third session of the AFI Symposium, titled <strong data-start=\"101\" data-end=\"236\">&#8220;<em>Digitalization, decentralization, Real World Evidence: how to make Italy and Europe competitive in the field of clinical research<\/em>&#8220;<\/strong>, aims to deepen the discussion on the factors that make a country attractive for conducting clinical research, with a specific focus on interventional and pharmacological clinical trials.<\/p>\n<p data-start=\"426\" data-end=\"985\">The discussion highlights two key elements: the ability to <strong data-start=\"485\" data-end=\"510\">start studies quickly<\/strong> and the <strong data-start=\"519\" data-end=\"543\">efficient enrollment<\/strong> of a large number of patients. It also emphasizes the importance of a <strong data-start=\"614\" data-end=\"634\">low dropout rate<\/strong>, which is essential for ensuring study completion and data integrity. The current state of clinical research in Italy will be compared with countries like <strong data-start=\"790\" data-end=\"799\">Spain<\/strong> and <strong data-start=\"804\" data-end=\"819\">Switzerland<\/strong>, with the goal of identifying best practices and enhancing European participation in clinical research, ultimately aiming to <strong data-start=\"945\" data-end=\"984\">revitalize investment in the sector<\/strong>.<\/p>\n<p data-start=\"987\" data-end=\"1428\">The panel of experts participating in the session, scheduled for <strong data-start=\"1052\" data-end=\"1063\">June 11<\/strong> in the <strong data-start=\"1071\" data-end=\"1106\">Castello 2 Room at Fiera Rimini<\/strong>, will examine both <strong data-start=\"1126\" data-end=\"1159\">digital and non-digital tools<\/strong> that support patient enrollment, such as pre-screening platforms via print media, real-world data sources, pharmacies, local healthcare services, and general practitioners. These tools help streamline patient inclusion, participation, and continuous health monitoring.<\/p>\n<p data-start=\"1430\" data-end=\"1796\">The final part of the session shifts focus to <strong data-start=\"1476\" data-end=\"1505\">real-world evidence (RWE)<\/strong> and how emerging technologies and new data can improve care pathways. The innovations discussed include <strong data-start=\"1610\" data-end=\"1630\">wearable devices<\/strong>, <strong data-start=\"1632\" data-end=\"1661\">remote patient monitoring<\/strong>, and <strong data-start=\"1667\" data-end=\"1697\">AI-based analytics systems<\/strong>, all of which contribute to a more <strong data-start=\"1733\" data-end=\"1795\">personalized, efficient, and sustainable healthcare system<\/strong>.<\/p>\n<p data-start=\"1798\" data-end=\"2293\">The session will highlight how these tools enable a shift from reactive to proactive care models, supporting more informed clinical decisions, improving outcomes, and optimizing resource allocation. Moreover, the <strong data-start=\"2011\" data-end=\"2039\">multidisciplinary nature<\/strong> of the discussion \u2013 bringing together representatives from the pharmaceutical and medical device industries, clinicians, and institutions \u2013 will offer a comprehensive overview and practical strategies to transform data into tangible health improvements.<\/p>\n<p data-start=\"2295\" data-end=\"2412\"><strong data-start=\"2295\" data-end=\"2312\">Ilaria Maruti<\/strong>, from AstraZeneca, and <strong data-start=\"2336\" data-end=\"2354\">Alice Porrello<\/strong>, from Roche, present the session in this video interview:<\/p>\n<p><iframe loading=\"lazy\" title=\"64\u00b0 AFI Symposium_2025_III Session\" width=\"696\" height=\"392\" src=\"https:\/\/www.youtube.com\/embed\/6g-VBXAFoEA?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n<p data-start=\"1678\" data-end=\"2176\">\n","protected":false},"excerpt":{"rendered":"<p>How to make Europe competitive in clinical research? This is the topic that will be discussed in the third session of the AFI Symposium<\/p>\n","protected":false},"author":32,"featured_media":23533,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1065],"tags":[],"class_list":{"0":"post-23501","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-afi-interview"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>64\u00b0 AFI Symposium | Maruti e Porrello about the third session - MakingPharmaIndustry<\/title>\n<meta name=\"description\" content=\"How to make Europe competitive in clinical research? This is the topic that will be discussed in the third session of the AFI Symposium\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"64\u00b0 AFI Symposium | Maruti e Porrello about the third session - MakingPharmaIndustry\" \/>\n<meta property=\"og:description\" content=\"How to make Europe competitive in clinical research? This is the topic that will be discussed in the third session of the AFI Symposium\" \/>\n<meta property=\"og:url\" content=\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/\" \/>\n<meta property=\"og:site_name\" content=\"MakingPharmaIndustry\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-22T09:39:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/05\/sessione-III-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Valentina Parrella\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Valentina Parrella\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/\"},\"author\":{\"name\":\"Valentina Parrella\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/6c2a2cb5a6dc47527ff5eb31dab7d42f\"},\"headline\":\"64\u00b0 AFI Symposium | Maruti e Porrello about the third session\",\"datePublished\":\"2025-05-22T09:39:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/\"},\"wordCount\":333,\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/05\/sessione-III-1.png\",\"articleSection\":[\"AFI Interview\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/\",\"name\":\"64\u00b0 AFI Symposium | Maruti e Porrello about the third session - MakingPharmaIndustry\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/05\/sessione-III-1.png\",\"datePublished\":\"2025-05-22T09:39:42+00:00\",\"author\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/6c2a2cb5a6dc47527ff5eb31dab7d42f\"},\"description\":\"How to make Europe competitive in clinical research? This is the topic that will be discussed in the third session of the AFI Symposium\",\"breadcrumb\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/#primaryimage\",\"url\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/05\/sessione-III-1.png\",\"contentUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/05\/sessione-III-1.png\",\"width\":1200,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/makingpharmaindustry.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"64\u00b0 AFI Symposium | Maruti e Porrello about the third session\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/\",\"name\":\"MakingPharmaIndustry\",\"description\":\"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/6c2a2cb5a6dc47527ff5eb31dab7d42f\",\"name\":\"Valentina Parrella\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"caption\":\"Valentina Parrella\"},\"url\":\"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"64\u00b0 AFI Symposium | Maruti e Porrello about the third session - MakingPharmaIndustry","description":"How to make Europe competitive in clinical research? This is the topic that will be discussed in the third session of the AFI Symposium","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/","og_locale":"en_US","og_type":"article","og_title":"64\u00b0 AFI Symposium | Maruti e Porrello about the third session - MakingPharmaIndustry","og_description":"How to make Europe competitive in clinical research? This is the topic that will be discussed in the third session of the AFI Symposium","og_url":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/","og_site_name":"MakingPharmaIndustry","article_published_time":"2025-05-22T09:39:42+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/05\/sessione-III-1.png","type":"image\/png"}],"author":"Valentina Parrella","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Valentina Parrella","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/#article","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/"},"author":{"name":"Valentina Parrella","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/6c2a2cb5a6dc47527ff5eb31dab7d42f"},"headline":"64\u00b0 AFI Symposium | Maruti e Porrello about the third session","datePublished":"2025-05-22T09:39:42+00:00","mainEntityOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/"},"wordCount":333,"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/05\/sessione-III-1.png","articleSection":["AFI Interview"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/","url":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/","name":"64\u00b0 AFI Symposium | Maruti e Porrello about the third session - MakingPharmaIndustry","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/#primaryimage"},"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/05\/sessione-III-1.png","datePublished":"2025-05-22T09:39:42+00:00","author":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/6c2a2cb5a6dc47527ff5eb31dab7d42f"},"description":"How to make Europe competitive in clinical research? This is the topic that will be discussed in the third session of the AFI Symposium","breadcrumb":{"@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/#primaryimage","url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/05\/sessione-III-1.png","contentUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/05\/sessione-III-1.png","width":1200,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/64-afi-symposium-maruti-e-porrello-about-the-third-session\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/makingpharmaindustry.it\/en\/"},{"@type":"ListItem","position":2,"name":"64\u00b0 AFI Symposium | Maruti e Porrello about the third session"}]},{"@type":"WebSite","@id":"https:\/\/makingpharmaindustry.it\/en\/#website","url":"https:\/\/makingpharmaindustry.it\/en\/","name":"MakingPharmaIndustry","description":"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/6c2a2cb5a6dc47527ff5eb31dab7d42f","name":"Valentina Parrella","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","caption":"Valentina Parrella"},"url":"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/"}]}},"_links":{"self":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/23501","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/comments?post=23501"}],"version-history":[{"count":6,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/23501\/revisions"}],"predecessor-version":[{"id":23699,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/23501\/revisions\/23699"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media\/23533"}],"wp:attachment":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media?parent=23501"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/categories?post=23501"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/tags?post=23501"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}